Product Information

MESALAMINE 4 GM/60 ML KIT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $135.1891 per EA under NDC 45802092341. Its NADAC has been published 387 times since Nov 28, 2013.

FDA first approved this application on Sep 17, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Mesalamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MESALAMINE 4 GM/60 ML KIT

Mesalamine
$135.1891per EA
High Outlier

NDC

45802092341

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076751

FDA Approved

9/17/2004

TE Code

AB

On Market Since

9/1/2009

Price Statistics

The NADAC for MESALAMINE 4 GM/60 ML KIT has been published 387 times since Nov 28, 2013, and over the history we have for it it has risen 30.1%. The table below summarizes its recorded NADAC range and movement.

Current price$135.1891 per EA
All-time high$146.9742 (May 11, 2016)
All-time low$102.9030 (Oct 22, 2014)
52-week high$135.1980
52-week low$116.3398
Median price$118.1314
Average price$121.1501
Largest weekly change+17.8% (Jun 17, 2015)
Weeks tracked387
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

+0.3%

6M

+15.8%

1Y

+14.9%

3Y

+16.4%

5Y

+0.9%

All

+30.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of MESALAMINE 4 GM/60 ML KIT?

The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE 4 GM/60 ML KIT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $135.1891 per EA (NDC 45802092341), effective Aug 19, 2026.

How has the price of MESALAMINE 4 GM/60 ML KIT changed over time?

Over the history we have for it, the NADAC for MESALAMINE 4 GM/60 ML KIT has risen 30.1%. It has been tracked across 387 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MESALAMINE 4 GM/60 ML KIT?

Since Nov 28, 2013, the NADAC for MESALAMINE 4 GM/60 ML KIT has ranged from a low of $102.9030 (Oct 22, 2014) to a high of $146.9742 (May 11, 2016), with a median of $118.1314 per EA.

Are there cheaper alternatives to MESALAMINE 4 GM/60 ML KIT?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MESALAMINE 4 GM/60 ML KIT in a comparable dosage form, but none are currently priced below it.

Who manufactures MESALAMINE 4 GM/60 ML KIT?

MESALAMINE 4 GM/60 ML KIT (NDC 45802092341) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.